The day 100 score predicts moderate to severe cGVHD, transplant mortality, and survival after hematopoietic cell transplantation

The aim of this study was to develop a predictive score for moderate-severe chronic graft-versus-host disease (cGVHD) on day +100 after allogeneic stem cell transplantation (HSCT). We studied 1292 patients allografted between 1990 and 2016, alive on day +100 after transplant, without cGVHD, and with...

Descripción completa

Detalles Bibliográficos
Autores principales: Metafuni, Elisabetta, Cavattoni, Irene Maria, Lamparelli, Teresa, Raiola, Anna Maria, Ghiso, Anna, Galaverna, Federica, Gualandi, Francesca, Di Grazia, Carmen, Dominietto, Alida, Varaldo, Riccardo, Signori, Alessio, Chiusolo, Patrizia, Sora’, Federica, Giammarco, Sabrina, Laurenti, Luca, Sica, Simona, Angelucci, Emanuele, Bacigalupo, Andrea
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society of Hematology 2022
Materias:
Transplantation
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9006267/
https://www.ncbi.nlm.nih.gov/pubmed/34920451
http://dx.doi.org/10.1182/bloodadvances.2021005675

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9006267/
https://www.ncbi.nlm.nih.gov/pubmed/34920451
http://dx.doi.org/10.1182/bloodadvances.2021005675

Ejemplares similares